Peter L. Meintjes PhD

Peter Meintjes is a chief commercial officer to lead the commercialization of the company's TruGraf blood test for kidney transplant surveillance. Meintjes joins TGI after six years at Omixon, where most recently served as CEO after having also held the roles of chief commercial officer and director of US operations. Meintjes also previously worked as VP of business development for Biomatters.